Delivery Order SPE2DB24D8003-SPE2DB25FJTNT

Award Date 12/30/24
Potential Completion Date 12/31/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D8003
    Indefinite Delivery Contract
  • SPE2DB24D8003-SPE2DB25FJTNT
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit Subchapter S corporation. The contract, valued at $1,747.34, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of December 31, 2024.

Dakota Drug, Inc. is a key supplier for the DLA's Troop Support Medical division, holding a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. This latest delivery order contract appears to be part of the company's broader work under the DLA's ECAT Generation V Program, which facilitates the efficient delivery of critical medical items to various defense healthcare facilities.

Generated 3/31/25, 9:35 AM